Dr. Garje on Survival Outcomes of Sarcomatoid Versus Classic Urothelial Carcinoma of Bladder

Описание к видео Dr. Garje on Survival Outcomes of Sarcomatoid Versus Classic Urothelial Carcinoma of Bladder

Rohan Garje, MD, Miami Cancer Institute, provides an overview of his comparison of survival outcomes of sarcomatoid urothelial carcinoma versus classic urothelial carcinoma in patients with T2-T4, N0-N1 bladder cancer after definitive therapy.

Комментарии

Информация по комментариям в разработке